Earning Call Chemicals & Petrochemicals NSE: UPL ·

UPL Ltd Reports 11% Revenue Growth in FY26 as PATMI More Than Doubles

NSE Filing 5 min read 1 views
UPL Ltd Reports 11% Revenue Growth in FY26 as PATMI More Than Doubles

UPL Ltd (512070) — Earning Call · UPL

FY26 Revenue

₹51,839 Cr

11% YoY Growth

Market Cap

₹55,630.7 Cr

Mid Cap

EBITDA Margin

18.5%

110 bps increase

Day RSI

51.28

Neutral Zone

! Key Highlights

  • Consolidated revenue for FY26 reached ₹51,839 crore, a YoY increase of 11% which outperformed management guidance.
  • EBITDA grew by 18% YoY with margins improving by 110 basis points to reach 18.5%.
  • Net Profit (PATMI) reached ₹1,921 crore, more than doubling the previous year's performance.
  • The Advanta seeds platform recorded a robust revenue growth of 23%, driven by optimized operating leverage.
  • Management successfully reduced gross debt by $850 million, achieving a Net Debt/EBITDA ratio of less than 1.6x.

UPL Ltd exceeded its annual guidance for FY26, reporting an 11% increase in revenue and a significant recovery in net profitability. The company achieved its deleveraging goals by reducing gross debt by $850 million, supported by strong volume growth across its global platforms.

Financial Performance and Profitability Recovery

UPL Ltd demonstrated a strong financial recovery in FY26, surpassing its initial revenue growth guidance of 4-8% to achieve a final growth of 11%. This performance was primarily volume-driven, with volumes increasing by 8% and foreign exchange tailwinds contributing another 6%, which helped offset a 3% decline in global pricing. The company's focus on cost efficiency and higher-margin brands led to an 18% growth in EBITDA.

The bottom line saw a substantial rebound, as PATMI reached ₹1,921 crore, reflecting the impact of improved operating margins and a disciplined approach to geographic scale.

Management Outlook and Strategic Deleveraging

A cornerstone of UPL's strategy during the fiscal year was the aggressive reduction of debt to strengthen the balance sheet. Management reported a gross debt reduction of $850 million, successfully hitting its target Net Debt to EBITDA ratio of under 1.6x. This fiscal discipline was acknowledged by global agencies, which upgraded the company's rating to 'Stable' in the first half of the year.

For FY27, management remains focused on sustaining profitable growth through geographic expansion and product diversification, while maintaining a lean capital expenditure budget of approximately $261 million for essential projects.

Business Overview and Segment Analysis

  • Advanta Platform: The seeds business was a major growth driver, posting a 23% revenue increase due to strong grower demand.
  • UPL Corp: The global crop protection business grew by 11% YoY, supported by focused brands like Centurion EZ and Tridium.
  • UPL SAS: The India-focused segment remained flat during the year, reflecting localized market dynamics and pricing pressures.
  • Pricing Dynamics: Volume growth of 8% was partially offset by a 3% price reduction, indicating a competitive global landscape.
  • Cash Flow: The company reported strong operating cash flows, contributing to the overall liquidity and debt repayment strategy.

Sector Dynamics and Emerging Challenges

The global agrochemical sector continues to face headwinds from lower commodity prices, which have placed stress on farm economics. Furthermore, geopolitical tensions and potential shifts in US trade tariffs present ongoing risks to global supply chains. Despite these pressures, UPL management noted resilient demand from growers for high-performance crop protection and seed solutions.

The company is positioning itself to navigate macro volatility by leveraging its diversified global footprint and its focus on biosolutions and innovative chemical formulations to maintain market share and pricing stability.

What to Watch

  • Sustenance of the Net Debt/EBITDA ratio below the 1.6x threshold in the upcoming quarters.
  • Impact of US tariff-related challenges and geopolitical situations on global export volumes.
  • Execution of new product launches in the biologicals segment to counter pricing pressure in traditional chemicals.
  • The impact of stabilizing commodity prices on farm spending and demand for premium agrochemical products.

UPL Ltd (512070) — Financial Snapshot

BSE: 512070 · NSE: UPL · Chemicals & Petrochemicals

Current Market Price ₹659 per share
Market Capitalisation ₹55,630.76 Cr BSE Listed
Revenue (Annual) ₹46,637.00 Cr Operating
Net Profit (Annual) ₹897.00 Consolidated
P/E Ratio (TTM) 31.66× Sector: 43.22×
Promoter Holding 33.51% +0.01% QoQ
FII Holding 41.78% Current Qtr

"UPL delivered a strong FY26 with 11% revenue growth and 18% EBITDA growth, outperforming its guidance."

— Management Commentary, Investor Presentation

Source Verified

Exchange filing by UPL Ltd announcing its audited financial results and investor presentation for the fiscal year ended March 31, 2026. Financial metrics from Trendlyne.

View Filing